Welcome to our dedicated page for Community Health Sys SEC filings (Ticker: CYH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Community Health Systems, Inc. (NYSE: CYH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Community Health Systems is a large operator in the general medical and surgical hospitals industry, with affiliates that own or lease hospitals and operate more than 1,000 sites of care across 36 distinct markets in 14 states. Its filings offer detailed information about hospital operations, financing activities, strategic transactions and governance matters.
Investors can review Current Reports on Form 8-K that describe material events such as offerings of senior secured notes, tender offers and redemptions of existing notes, and entries into or completions of significant purchase agreements. Recent 8-K filings outline the issuance of 9.750% Senior Secured Notes due 2034, the tender offer for 5.625% Senior Secured Notes due 2027, and subsequent redemptions, as well as the completion of asset sales and divestitures of ownership interests in hospitals and related businesses.
The filings also cover acquisition and disposition transactions, including significant dispositions that require unaudited pro forma condensed consolidated financial statements. These documents explain how the sale of hospital ownership interests or ambulatory outreach laboratory assets affects the company’s reported financials. Item 2.01 disclosures and related exhibits provide the underlying purchase agreements and pro forma information.
Governance and executive changes are documented in Item 5.02 sections of Form 8-K, where Community Health Systems reports appointments of its Chief Executive Officer, Chief Financial Officer and Chief Accounting Officer, as well as retirement and consulting arrangements for former executives. These filings describe role transitions, responsibilities and, in some cases, compensation arrangements.
On Stock Titan, CYH filings are updated as new documents are posted to EDGAR, and AI-powered tools summarize key points from lengthy filings. Users can quickly identify major financing actions, divestitures, leadership changes and other material events without reading every page of the underlying documents, while still having direct access to the full SEC filings for deeper review.
Community Health Systems, Inc. reports its full-year 2025 results and outlines strategy and industry trends. Net operating revenues were $12,485 million, roughly flat year over year, while net income attributable to stockholders improved to $509 million, reversing prior-year losses.
The company operated 69 hospitals with 10,458 licensed beds and 8,983 beds in service at December 31, 2025, plus more than 1,000 outpatient sites. Same-store net operating revenues rose 4.6%, and income from operations on a same-store basis increased 7.2%, with adjusted EBITDA margin holding at 12.2%.
Operating cash flow strengthened to $543 million, and the company generated $847 million of net cash from investing activities while using $1,167 million in financing activities, reflecting significant debt activity and divestitures. Management highlights initiatives in regional networks, outpatient expansion, productivity, quality programs and adaptation to evolving Medicare, Medicaid and commercial payor dynamics.
Community Health Systems, Inc. reported a sharp turnaround for 2025, moving to net income attributable to stockholders of $509 million or $3.77 per diluted share from a loss of $(516) million or $(3.90) in 2024. Full-year net operating revenues slipped 1.2% to $12.485 billion, but same-store revenue rose 4.6%, showing growth in the ongoing portfolio.
Adjusted EBITDA for 2025 was broadly flat at $1.526 billion, while net cash from operating activities increased to $543 million. Results benefited significantly from $406 million of net non-cash gains on divestitures and asset sales. The company executed a major portfolio reshaping, selling multiple hospitals and its lab outreach business, and received $1.254 billion of hospital and ancillary sale proceeds.
Leverage improved as $445 million of 10.875% senior secured notes due 2032 and all $14 million of 5.625% notes due 2027 were redeemed, helping reduce long-term debt to $10.380 billion. For 2026, management guides to net operating revenues of $11.6–$12.0 billion, Adjusted EBITDA of $1.34–$1.49 billion, and diluted EPS between $(0.60) and $0.00, reflecting expected pressure from divestitures and interest expense.
Community Health Systems Inc. attracted a new significant shareholder disclosure. Investment entities including CastleKnight Master Fund LP, CastleKnight Fund GP LLC, CastleKnight Management LP, CastleKnight Management GP LLC, Weitman Capital LLC, and individual investor Aaron Weitman reported beneficial ownership of 9,748,536 shares of Class A common stock, equal to 7.0% of the outstanding class as of the event date. All reporting persons list zero sole voting or dispositive power and instead share voting and dispositive power over the same 9,748,536 shares. They certify that the position is not held for the purpose of changing or influencing control of Community Health Systems, indicating a passive investment stance.
Community Health Systems, Inc. (CYH) received an amended Schedule 13G/A showing that Eversept Partners, L.P., Eversept 1 LLC and Kamran Moghtaderi jointly report beneficial ownership of 7,943,802 shares of common stock, representing 5.73% of the outstanding class as of the event date.
The reporting persons disclose sole voting and dispositive power over 6,911,186 shares and shared voting and dispositive power over 1,032,616 shares. They state the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Community Health Systems.
Apollo Capital Management, Apollo Management Holdings and affiliated funds report beneficial ownership of 11,838,609 shares of Community Health Systems, Inc. common stock, representing 8.5% of the class. The percentage is based on 138,519,615 shares outstanding as of October 17, 2025, from the company’s Form 10-Q.
The Apollo complex reports no sole voting or dispositive power and shared voting and dispositive power over these shares through multiple investment vehicles, including Apollo Credit Strategies Master Fund Ltd., AAA Multi-Asset Credit Strategies Fund (Z), L.P. and others. Several Apollo entities and executives expressly disclaim beneficial ownership of the shares.
The filing is an Amendment No. 3 to Schedule 13G, indicating the position is reported on a passive basis. The signatory certifies that the securities were not acquired and are not held for the purpose of changing or influencing control of Community Health Systems, other than limited activities related to director nominations under the cited SEC rule.
Community Health Systems, Inc. approved 2026 compensation packages for three top executives, including CEO Kevin J. Hammons, CFO Jason K. Johnson and EVP Kevin A. Stockton. Base salaries were set at $1,250,000 for Hammons, $630,000 for Johnson and $740,000 for Stockton.
The Board also set annual cash incentive targets as percentages of salary, with Hammons at 215%, Johnson at 115% and Stockton at 95%, plus additional upside for non-financial improvements and overachievement of goals. Long-term incentives include stock options, time-vesting restricted stock and performance-based restricted stock granted on March 1, 2026, with performance awards measured over 2026–2028 and vesting outcomes ranging from 0% to 200% of target.
Community Health Systems, Inc. completed the sale of its CHS subsidiary’s 80% ownership interest in joint ventures that own and operate Tennova Healthcare – Clarksville and related ancillary businesses to Vanderbilt University Medical Center and its affiliates. The CHS selling entity received $623 million in cash, subject to a post-closing working capital adjustment. Separately, CHS subsidiaries paid approximately $23 million in cash to the purchaser to settle the purchaser’s share of amounts owed to the joint ventures by CHS. The company classified this as a significant disposition and filed unaudited pro forma condensed consolidated financial statements to show the impact of the transaction.
Community Health Systems, Inc. has agreed to sell Crestwood Medical Center in Huntsville, Alabama, and related businesses through an asset purchase agreement between its wholly owned subsidiary CHS/Community Health Systems, Inc. and The Health Care Authority of the City of Huntsville, doing business as Huntsville Hospital Health System.
The purchaser will pay a total purchase price of $450 million at closing, subject to adjustments for net working capital and any finance leases it assumes. The parties have exchanged detailed representations, warranties, covenants and indemnification obligations, and closing is subject to specified conditions, with completion currently expected in the second quarter of 2026. The agreement may be terminated by either party in certain situations, including if the transaction is not completed on or before June 1, 2026, and the parties plan to enter transition services agreements so CHS can provide information technology and operational support for a period after closing.
Community Health Systems Inc. insider Phillip A. Posey, who serves as SVP & Chief Accounting Officer, filed an initial ownership report. The filing shows that he beneficially owns 27,924 shares of the company’s common stock, held directly. The report relates to an event dated 01/01/2026 and is signed by Christopher G. Cobb as attorney-in-fact for Posey on 01/05/2026. No derivative securities are listed in the disclosure.
Community Health Systems director equity activity: On 12/31/2025, a director of Community Health Systems, Inc. converted 2,882 stock units into shares of common stock at an exercise price of $0 under the company’s Directors' Fees Deferral Plan. After this transaction, the director beneficially owned 362,281 shares of common stock directly and 4,990 shares indirectly through E5 Investors LLC.
The filing also shows ongoing deferred compensation and equity awards. The director holds 13,085.472 stock units and several blocks of restricted stock units, including 53,779, 9,756, 41,812, and 59,801 units. These units generally vest in one‑third increments on the first, second, and third anniversaries of the grant date and will be settled on a one‑for‑one basis in shares of common stock, either upon or following the director’s cessation of service, depending on prior deferral elections.